Determination of locally advanced basal cell carcinoma (BCC) in the first 285 patients enrolled in the RegiSONIC disease registry study.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Northwestern University, Stanford Medicine, Stanford University, Tufts University, The Ohio State University Wexner Medical Center, The Ohio State University, Memorial Sloan Kettering Cancer Center, Emory University, Winship Cancer Institute, University of California, San Francisco, Genentech, Mayo Clinic in Arizona
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2592229947
